Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$476.27 USD

476.27
490,764

+2.99 (0.63%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $476.27 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Idexx (IDXX) Hits 52-Week High, Can the Run Continue?

Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Top Ranked Momentum Stocks to Buy for October 13th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 13th.

The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck & Co., Chipotle Mexican Grill and IDEXX Laboratories

The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck & Co., Chipotle Mexican Grill and IDEXX Laboratories

Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

Is (IDXX) Outperforming Other Medical Stocks This Year?

Sheraz Mian headshot

Top Analyst Reports for Alibaba, UnitedHealth & Merck

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), UnitedHealth Group (UNH) and Merck (MRK).

Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?

Style Box ETF report for JHMM

Idexx (IDXX) Up 2.6% Since Last Earnings Report: Can It Continue?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?

Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise

IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.

Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

Is (IDXX) Outperforming Other Medical Stocks This Year?

Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Will Epidolex Drive GW Pharmaceuticals' (GWPH) Q2 Earnings?

Amid the pandemic situation, GW Pharmaceuticals (GWPH), which controls its own manufacture and supply chain, is expected to have faced minimum supply-related disruption unlike others.

Illumina (ILMN) to Report Q2 Earnings: What's in the Offing?

Illumina (ILMN) is upbeat about its second-quarter sequencing consumable revenue growth.

Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

What's in the Cards for CVS Health (CVS) in Q2 Earnings?

CVS Health's (CVS) consumer centric digital strategy becomes even more relevant in Q2 with people increasingly using technology while staying at home.

STAAR Surgical (STAA) to Report Q2 Earnings: What's in Store?

STAAR Surgical's (STAA) ICL line of products is likely to have boosted Q2 performance amid the coronavirus pandemic.

STERIS (STE) to Report Q1 Earnings: What's in the Cards?

STERIS (STE) registers declines in Healthcare Products with neutral performance in Life Science and AST in April, which is likely to have impacted Q1 earnings.

Zimmer Biomet (ZBH) to Report Q2 Earnings: What's in Store?

Zimmer Biomet's (ZBH) Hips and Knees portfolios are expected to have contributed to second-quarter top line despite pandemic-led business disruptions.

Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

Henry Schein's (HSIC) medical business' PPE sales are likely to have boosted Q2 performance amid the coronavirus pandemic.

What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

IDEXX's (IDXX) top line is likely to have benefited from a robust CAG business and regulatory approvals for its COVID-19 tests.

Deferred Procedures to Mar Boston Scientific (BSX) Q2 Earnings

With lockdowns continuing through all three months of the second quarter, Boston Scientific (BSX) is expected to have faced a more dreadful time.

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice

Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Urmimala Biswas headshot

Medical Instruments Outlook Dull Amid Coronavirus Crisis

Many sub domains within the medical instrument space are bearing the brunt of the coronavirus-led prolonged stay-at-home orders.

IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.